Navigation Links
Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
Date:4/17/2008

y different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical studies may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. In addition, Anadys' results may be affected by risks related to competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to successfully develop and market products, difficulties or delays in its preclinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments involving future products and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2007. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.


'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize ... guide the use of IRESSA  for non-small cell lung ... on QIAGEN,s FDA-approved  therascreen   EGFR test and is planned ... automated instruments  Project enabled by AstraZeneca master ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6OmPrompt Funded for Customer Automation Management Market Expansion 2
(Date:7/28/2014)... 2014 Ticket Down is a ... in Miami, FL at the Sun Life Stadium in early ... between Argentina and Brazil has is one that has continues ... rivalries are forming on a consistent basis. The rivalry ... height in the recent 2014 World Cup. To the ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) -- British researchers report ... far fewer germs around. In their experiments, the ... more germs from one person to the other than ... the more casual exchange might suffice as a cultural ... findings are published in the August issue of the ...
(Date:7/28/2014)... is enough oxygen present to support their offspring, but ... rule. Researchers at The Johns Hopkins University have now ... enabling cancers to continue to divide even without a ... that lysosomes the cell,s protein "recycling centers" ... evidence that certain drugs can halt the growth of ...
(Date:7/28/2014)... July 28, 2014 The Oakwood Foundation ... Birkhill, Wang, Songe and Associates, PC that will benefit ... tomorrows to come. , The HBWS group is ... more than $2.5 million in donations. Through their latest ... for the Oakwood Women’s Healthcare Classic for the next ...
(Date:7/28/2014)... Salt Lake City, Utah (PRWEB) July 28, 2014 ... supplements, protein powders and drinks, announced that it will ... protein drink line of products this summer. The additional ... combined with clean pure taste-free protein , Inspire Pomegranate ... Inspire Vanilla - flavor of soft-serve vanilla cone , ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Cell's recycling center implicated in division decisions 2Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2
... May 8, 2012 Poor women and African Americans ... standards of care, leading to worse outcomes than among white ... presented by UC Irvine,s Dr. Robert Bristow at the Society ... women are benefiting equally from improvements in ovarian cancer care," ...
... , TUESDAY, May 8 (HealthDay News) -- Sperm cells ... tract by crawling along walls and swimming around corners, ... sperm cells are ejaculated, the few that actually reach ... new insight on how sperm travel could help scientists ...
... PHILADELPHIA - All cells have the ability to recycle unwanted ... But cancer cells have ramped up the system, called autophagy, ... of chemotherapy and other treatments. Now, researchers at the Perelman ... of Arts and Sciences, at the University of Pennsylvania, have ...
... By Maureen Salamon HealthDay Reporter , ... the counties in the United States lack a single ... graduates gravitate toward metropolitan areas, a new study indicates. ... without obstetrician-gynecologists (ob-gyns); this scarcity is more prevalent in ...
... 2012) The American Gastroenterological Association (AGA) ... (PIM) has received approval from the American ... part of ABIM,s Approved Quality Improvement (AQI) ... internal medicine subspecialists using procedural sedation can ...
... Review: Screening Women for Intimate Partner Violence May Have ... or IPV, includes a range of abusive behaviors perpetrated ... the victim. Abusive behaviors may include physical violence, sexual ... have immediate health effects on the victim. While victims ...
Cached Medicine News:Health News:UC Irvine study finds racial, economic disparities in ovarian cancer care, survival 2Health News:Sperm Collide Along Liquid Maze on Way to Fertilize Egg 2Health News:Block its recycling system, and cancer kicks the can, according to new Penn study 2Health News:Half of U.S. Counties Have No Ob-Gyn: Study 2Health News:AGA releases first independently developed ABIM-approved Practice Improvement Module in GI 2Health News:Annals of Internal Medicine tip sheet for May 8, 2012, online issue 2
Protective Curtain for Barriers can be used on any of our RayShield® Barriers. Whether they are ordered with the barrier or as a retrofit, RayShield Protective Curtains are easy to install with s...
Front Protection with attached Belt Guard, Built-in Back Support; Buckle Closure...
Pregnancy Apron...
All Day Comfort for the Upper Body...
Medicine Products: